Evidence map›Paper›PMID 34342575›Full record

ArticleeLife2021

A precisely adjustable, variation-suppressed eukaryotic transcriptional controller to enable genetic discovery.

Asli Azizoglu, Roger Brent, Fabian Rudolf

Abstract read
In one paragraph

Article in eLife, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A Fkh1/2 binding site array in thebioRxiv : the preprint server for biology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Asli AzizogluComputational Systems Biology and Swiss Institute of Bioinformatics, ETH Zurich, Basel, Switzerland.ORCID 0000-0002-2600-1322
Roger Brent *Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, United States.ORCID 0000-0001-8398-3273
Fabian Rudolf *Computational Systems Biology and Swiss Institute of Bioinformatics, ETH Zurich, Basel, Switzerland.

Funding

Precision controllers of mammalian gene expressionR21CA223901 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRENT, ROGER · 2018 to 2020
$695k
NCI NIH HHS R21 CA223901
6 · The paper itself

Abstract

Conditional expression of genes and observation of phenotype remain central to biological discovery. Current methods enable either on/off or imprecisely controlled graded gene expression. We developed a 'well-tempered' controller, WTC

Indexed as

AllelesCdc20 ProteinsCDC28 Protein Kinase, S cerevisiaecdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell Cycle ProteinsFungal ProteinsGene Expression Regulation, FungalPhenotypePromoter Regions, GeneticSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsCdc20 ProteinsCDC20 protein, S cerevisiaeCDC28 Protein Kinase, S cerevisiaecdc42 GTP-Binding Protein, Saccharomyces cerevisiaeCell Cycle ProteinsFungal ProteinsSaccharomyces cerevisiae Proteinscell-to-cell variationchromosomesessential gene allelesgene expressiongenetic discoverygeneticsgenomicsinducible gene expressionprotein dosageS. cerevisiaetranscriptional control

Identifiers

PMID34342575
PMCPMC8421071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.